SLC2A9 and hyperuricemia: Genetic variants affecting renal and extrarenal urate transporters, such as URAT1, SLC2A9, and ABCG2, play a critical role by determining individual susceptibility to hyperuricemia and subsequent gout through their effects on serum urate reabsorption and excretion [9–12].